Phreesia, Inc. (PHR)
Market Cap | 1.18B |
Revenue (ttm) | 373.67M |
Net Income (ttm) | -119.08M |
Shares Out | 57.40M |
EPS (ttm) | -2.16 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 297,400 |
Open | 20.70 |
Previous Close | 20.67 |
Day's Range | 20.28 - 20.80 |
52-Week Range | 12.05 - 34.98 |
Beta | 0.92 |
Analysts | Buy |
Price Target | 30.92 (+50.83%) |
Earnings Date | May 30, 2024 |
About PHR
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to d... [Read more]
Financial Performance
In 2023, Phreesia's revenue was $356.30 million, an increase of 26.84% compared to the previous year's $280.91 million. Losses were -$136.89 million, -22.29% less than in 2022.
Financial StatementsAnalyst Forecast
According to 13 analysts, the average rating for PHR stock is "Buy." The 12-month stock price forecast is $30.92, which is an increase of 50.83% from the latest price.
News
![](https://cdn.snapi.dev/images/v1/d/c/press9-2506940.jpg)
Phreesia, Inc. (PHR) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federa...
![](https://cdn.snapi.dev/images/v1/p/3/press8-2506938.jpg)
Levi & Korsinsky Announces an Investigation on Behalf of Phreesia, Inc. (PHR) Shareholders Who May Have Been Affected by Fraud
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federa...
![](https://cdn.snapi.dev/images/v1/x/v/press19-2506907.jpg)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHR
NEW YORK , July 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. ("Phreesia" or the "Company") (NYSE: PHR). Such investors are advised to contact ...
![](https://cdn.snapi.dev/images/v1/z/m/press4-2506274.jpg)
Levi & Korsinsky Reminds Phreesia Investors of the Ongoing Investigation into Potential Violations of Securities Laws - PHR
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federa...
![](https://cdn.snapi.dev/images/v1/b/4/press4-2503712.jpg)
PHR STOCK ALERT: Levi & Korsinsky Notifies Phreesia, Inc. Investors of an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / June 30, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of feder...
![](https://cdn.snapi.dev/images/v1/a/w/press3-2503710.jpg)
Lost Money on Phreesia, Inc.(PHR)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / June 30, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of feder...
![](https://cdn.snapi.dev/images/v1/p/w/press19-2503704.jpg)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHR
NEW YORK, June 30, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). Such investors are advised to cont...
![](https://cdn.snapi.dev/images/v1/l/r/press11-2502732.jpg)
ATTENTION PHR SHAREHOLDERS: Investors who lost money on Phreesia, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation
NEW YORK, NY / ACCESSWIRE / June 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of feder...
![](https://cdn.snapi.dev/images/v1/b/p/press15-2488204.jpg)
Phreesia, Inc. (PHR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK, NY / ACCESSWIRE / June 20, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. ("Phreesia" or "the Company") (NYSE:PHR). Inv...
![](https://cdn.snapi.dev/images/v1/0/2/press3-2471328.jpg)
New Research Illustrates How to Drive Earlier Diagnosis and Treatment of Kidney Disease
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia partners with the National Kidney Foundation and shares new research on early diagnosis and treatment of kidney disease.
![](https://cdn.snapi.dev/images/v1/f/x/press12-2470310.jpg)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHR
NEW YORK, NY / ACCESSWIRE / June 9, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. ("Phreesia" or the "Company") (NYSE:PHR). Such investors are advised to contac...
![](https://cdn.snapi.dev/images/v1/u/z/press2-2454893.jpg)
Phreesia Announces First Quarter Fiscal 2025 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2024. "I a...
![](https://cdn.snapi.dev/images/v1/i/g/press4-2449389.jpg)
Phreesia Joins the MEDITECH Alliance Program as an Innovator Partner
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has joined the MEDITECH Alliance Program as an Innovator Partner.
![](https://cdn.snapi.dev/images/v1/y/a/press11-2446450.jpg)
Phreesia's Amy Patel Named One of PM360's 2024 ELITE 100
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is pleased to announce that PM360 has named Amy Patel, MPH, Director of Analytics, as one of its 2024 PM360 ELITE 100.
![](https://cdn.snapi.dev/images/v1/n/b/press16-2442480.jpg)
Phreesia Named as One of Modern Healthcare's “Best Places to Work in Healthcare” for the Eighth Time
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been selected by Modern Healthcare as one of the 2024 Best Places to Work in Healthcare.
![](https://cdn.snapi.dev/images/v1/h/c/press4-2402193.jpg)
Phreesia's Alicia Cowley and Natasha Vega Named to MM+M's ‘Women to Watch' for 2024
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia's Director of Clinical Content Alicia Cowley and Senior Client Experience Manager Natasha Vega named to MM+M's Women to Watch class of 20...
![](https://cdn.snapi.dev/images/v1/c/h/press4-2396604.jpg)
Phreesia Sets Release Date for Fiscal First Quarter 2025 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia today announced that it will release its fiscal first quarter 2025 financial results after the close of market trading on May 30, 2024.
![](https://cdn.snapi.dev/images/v1/4/f/press10-2330463.jpg)
Phreesia Announces Jack Callahan as New Chief Technology Officer
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, has named Jack Callahan as the company's new Chief Technology Officer.
![](https://cdn.snapi.dev/images/v1/n/3/press2-2325309.jpg)
Phreesia Announces Fourth Quarter Fiscal 2024 Results
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2024. "Phr...
![](https://cdn.snapi.dev/images/v1/r/j/press15-2297006.jpg)
Phreesia's Hilary Hatch Again Named to the 2024-2025 NQF Leadership Consortium
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announces that its Chief Clinical Officer Hilary Hatch, PhD, has been selected to participate in NQF's 2024-2025 Leadership Consortium.
![](https://cdn.snapi.dev/images/v1/q/v/press7-2260820.jpg)
Phreesia Sets Release Date for Fiscal Fourth Quarter 2024 Results
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia will release its fiscal fourth quarter 2024 financial results after the close of market trading on Thursday, March 14, 2024.
![](https://cdn.snapi.dev/images/v1/b/p/press14-2239794.jpg)
Phreesia Joins Call to Action to Improve Adult Vaccination Rates
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is pleased to announce it has joined the National Adult and Influenza Immunization Summit's Call to Action for Adult Immunizations campaign.
![](https://cdn.snapi.dev/images/v1/g/z/press18-2231457.jpg)
Phreesia's Audrey Gato Named as a Top Woman Leader in SaaS
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Audrey Gato, Vice President of Client Solutions, has been named to The Softw...
![](https://cdn.snapi.dev/images/v1/x/s/press1-2225335.jpg)
Phreesia's Post-Script Engagement named one of PM360's 2023 Most Innovative Technologies
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia's Post-Script Engagement has been named to PM360's list of its 2023 Most Innovative Marketing Technologies or Services.
![](https://cdn.snapi.dev/images/v1/u/q/press3-2184618.jpg)
Phreesia Announces Third Quarter Fiscal 2024 Results
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2023. "I am proud of our wo...